110 related articles for article (PubMed ID: 29759660)
1. Extensive serum biomarker analysis in patients with nasopharyngeal carcinoma.
Gong D; Li Z; Ding R; Cheng M; Huang H; Liu A; Kang M; He H; Xu Y; Shao J; Wang Y; Duan C
Cytokine; 2019 Jun; 118():107-114. PubMed ID: 29759660
[TBL] [Abstract][Full Text] [Related]
2. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
Jin YB; Zhang GY; Lin KR; Chen XP; Cui JH; Wang YJ; Luo W
PLoS One; 2017; 12(2):e0172264. PubMed ID: 28207826
[TBL] [Abstract][Full Text] [Related]
3. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
Feng X; Lin J; Xing S; Liu W; Zhang G
BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.
Tan G; Liu Q; Tang X; Kang T; Li Y; Lu J; Zhao X; Tang F
BMC Cancer; 2016 Mar; 16():241. PubMed ID: 26995190
[TBL] [Abstract][Full Text] [Related]
5. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Cheng D; Kong H; Li Y
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):503-9. PubMed ID: 23749058
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival.
Chang KP; Chang YT; Wu CC; Liu YL; Chen MC; Tsang NM; Hsu CL; Chang YS; Yu JS
Head Neck; 2011 Jun; 33(6):886-97. PubMed ID: 21560180
[TBL] [Abstract][Full Text] [Related]
8. AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.
Li Y; Wang W; Liu Z; Jiang Y; Lu J; Xie H; Tang F
Clin Chim Acta; 2018 Sep; 484():323-327. PubMed ID: 29269202
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: A meta-analysis and systematic review.
Yang H; Wang K; Liang Z; Guo S; Zhang P; Xu Y; Zhou H
Clin Otolaryngol; 2020 Mar; 45(2):167-176. PubMed ID: 31573757
[TBL] [Abstract][Full Text] [Related]
10. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
[TBL] [Abstract][Full Text] [Related]
11. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
12. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum granulysin as a potential biomarker for nasopharyngeal carcinoma.
Lin J; Huang Y; Zhang L; Tang W; Li X; Wang X; Liu W
Clin Chim Acta; 2016 Feb; 454():72-6. PubMed ID: 26751807
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.
Qi X; Li X; Sun X
Tumour Biol; 2016 Aug; 37(8):11099-104. PubMed ID: 26910773
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma.
Mo HY; Luo DH; Qiu HZ; Liu H; Chen QY; Tang LQ; Zhong ZL; Huang PY; Zhao ZJ; Zhang CQ; Zhang Y; Mai HQ
Clin Oncol (R Coll Radiol); 2013 May; 25(5):308-17. PubMed ID: 23290342
[TBL] [Abstract][Full Text] [Related]
16. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
[TBL] [Abstract][Full Text] [Related]
17. Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy.
Zhang G; Zhang K; Li C; Li Y; Li Z; Li N; Zhou Q; Shen L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040200
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of IGF-1 serum levels as diagnostic marker of nasopharyngeal carcinoma.
M'hamdi H; Baizig NM; ELHadj OE; M'hamdi N; Attia Z; Gritli S; Gamoudi A; El May MV; A El May
Immunobiology; 2016 Nov; 221(11):1304-8. PubMed ID: 27312888
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of serum cytokines in patients with nasopharyngeal carcinoma.
Lu K; Feng X; Deng Q; Sheng L; Liu P; Xu S; Su D
Onkologie; 2012; 35(9):494-8. PubMed ID: 23007146
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases.
Wei Z; Zeng X; Xu J; Duan X; Yang J; Xie Y
Head Neck; 2014 Jan; 36(1):71-6. PubMed ID: 23728904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
